Australian Pharmaceuticals Industries Limited (ASX: API) has sold its stake in Sigma Healthcare Limited. The company sold whole interest in Sigma and now it holds no shares in Sigma.
- Selling stake in Sigma will allow API to increase its focus on its portfolio of business;
- The company is confident that the combination of its businesses will produce sustained shareholders value in the coming years.
At AEDT 1:34 PM, the stock was trading at $1.292 per share, up by 0.15% from its previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.